Pirfenidone Capsule
Product Images NDC 69238-1642

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 69238-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Pirfenidone Capsules Us Mfd 1)

Chemical structure diagram of pirfenidone, showing its molecular framework including a pyridone ring bonded to a phenyl group and a methyl substituent.*

FDA Label Image

10 (Pirfenidone Capsules Us Mfd 2)

A cumulative distribution plot showing the percentage of patients on the vertical axis versus the absolute change in % predicted forced vital capacity (FVC) from baseline to week 52 on the horizontal axis. Two lines compare Pirfenidone (black solid line, n=278) and placebo (gray dashed line, n=277) groups. The graph indicates worsening (decrease in %FVC) to the left and no decline (increase in %FVC) to the right, with annotated percentages at key points on the curves.*

FDA Label Image

10 (Pirfenidone Capsules Us Mfd 3)

A line graph depicting the mean change in forced vital capacity (FVC) in milliliters over 52 weeks, comparing Pirfenidone and placebo groups. The x-axis represents weeks, and the y-axis represents mean change in FVC, showing two lines for Pirfenidone (n=278) and placebo (n=277), illustrating a slower decline in FVC for Pirfenidone compared to placebo over time.*

FDA Label Image

10 (Pirfenidone Capsules Us Mfd 4)

A survival curve chart comparing the percentage of patients alive over time in weeks for Pirfenidone versus placebo groups. The chart plots patient survival up to 120 weeks, showing Pirfenidone (n=623) with a slightly higher survival compared to placebo (n=624), alongside patient counts at risk for both groups at several time points.*

FDA Label Image

Ifc (Pirfenidone Capsules Us Mfd 5)

Packaging label for Pirfenidone Capsules 267 mg oral capsules, distributed by Amneal Pharmaceuticals LLC. The label shows the NDC number 69238-1642, quantity of 270 capsules, and storage instructions. The label features the Amneal logo and a capsule image with "AMNEAL 1642" printed on it.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.